HCPCS Level IIdrugActive
J1449
Inj eflapegrastim-xnst 0.1mg
BETOS: O1E
Effective: 2023-04-01
Referenced in 1 policies
Description
Injection, eflapegrastim-xnst, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rolvedon
Manufacturer
Spectrum Pharmaceuticals, Inc.
HCPCS Dosage
0.1 MG
Billing Units
132.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.